Neonatal <scp>CARD14</scp> ‐Associated Papulosquamous Eruption: Response to Secukinumab During Infancy
Neonatal erythroderma is a rare but serious condition characterized by generalized erythema and scaling present from birth or shortly after. We report a case of neonatal erythroderma in a 3-week-old male related to a heterozygous mutation in the CARD14 gene. The successful use of secukinumab adds an additional case to underscore the potential of targeted biologic therapies in treating severe neonatal inflammatory conditions.
Authors
- Sílvia Planas (ORCID: https://orcid.org/0000-0003-1509-1681)
- Cristian Launes (ORCID: https://orcid.org/0000-0002-0913-9303)
- Eulàlia Baselga (ORCID: https://orcid.org/0000-0003-1086-8439)
- Álvaro March‐Rodríguez (ORCID: https://orcid.org/0000-0002-4637-7079)
- Ramón M. Pujol
- Helena Escolà
- Lilia Sánchez
- Luis A. Pérez‐Jurado (ORCID: https://orcid.org/0000-0002-1988-3005)
- Ana García‐García (ORCID: https://orcid.org/0000-0002-9900-9376)
- Asunción Vicente
Institutions
- Hospital Sant Joan de Déu Barcelona (ES)
- Universitat Pompeu Fabra (ES)
- Centre for Biomedical Network Research on Rare Diseases (ES)
- Hospital Clínic de Barcelona (ES)
- Hospital Del Mar (ES)
- Universitat de Barcelona (ES)
Publication Details
- Journal
- Pediatric Dermatology
- Published
- 2025-06-17
- DOI
- https://doi.org/10.1111/pde.16003
- Citations
- 1
- Primary Topic
- Skin and Cellular Biology Research
- Type
- article
- Field-Weighted Citation Impact
- 1.15